| Literature DB >> 21509151 |
Zhigang Song1, Chunkai Yu, Xin Song, Lixin Wei, Aijun Liu.
Abstract
Solitary fibrous tumor (SFT) is a rare spindle-cell neoplasm, especially in the thyroid. We report a case of primary solitary fibrous tumor of the thyroid gland in a 37 year-old Chinese man. The tumor was characterized by bland-looking spindle cells admixed with thin and thick collagen fibers. On immunohistochemistry study indicated that tumor cells were diffusely positive for CD34, Bcl-2 and CD99, and negative for Desmin, NSE, SMA, S-100, and CD68. The patient remains well 16 months after excision. The morphologic and immunohistochemical features of the thyroid SFTs are similar to their reported counterparts in other anatomic sites.Entities:
Keywords: solitary fibrous tumor; thyroid
Year: 2011 PMID: 21509151 PMCID: PMC3079918 DOI: 10.7150/jca.2.206
Source DB: PubMed Journal: J Cancer ISSN: 1837-9664 Impact factor: 4.207
Fig 1Gross specimen of the SFT of the thyroid. A solid, well-circumscribed, white nodule with whitish cut surface.
Fig 2Histological examination of the SFT of the thyroid. 2A: The capsule of thyroid is not involved, while the entrapped follicles can be seen.(H&E staining, original magnification 40x), 2B: The tumor cells are abundant with whorled arrangement. (H&E staining, original magnification 100x)
Fig 3The immunohistochemical staining of the SFT of the thyroid (EnVision method), showing positive for CD34 (A, original magnification 100x), bcl-2 (B, original magnification 100x), CD99 (C, original magnification 40x), and lower Ki-67 index (D, original magnificaion 100x, the up-right inserted picture 400x), respectively.
Reported cases of thyroid solitary fibrous tumor
| Case | Gender | Age | Size (cm) | Site | Follow up (month) | Reference |
|---|---|---|---|---|---|---|
| 1 | F | 44 | 6.5 | R | NED, 60 | |
| 2 | M | 61 | 6 | L | NED, 48 | |
| 3 | F | 32 | 3.5 | R | NED, 60 | |
| 4 | M | 43 | 4 | NA | NED, 160 | |
| 5 | F | 48 | 8 | R | NA | |
| 6 | F | 28 | 2.5 | NA | LTF | |
| 7 | F | 43 | 3.5 | L | LTF | |
| 8 | M | 52 | 2.5 | L | LTF | |
| 9 | M | 44 | 2 | L | LTF | |
| 10 | F | 64 | 4.5 | R | NED, 60 | |
| 11 | M | 53 | 6 | L | NED, 60 | |
| 12 | F | 47 | 4.5 | R | NED, 48 | |
| 13 | F | 64 | 3 | L | NA | |
| 14 | M | 56 | 8 | R | NED, 12 | |
| 15 | M | 68 | 9.7 | L | NED, 54 | |
| 16 | M | 45 | 5 | L | NA | |
| 17 | M | 64 | 5 | R | NED, 57 | |
| 18 | M | 41 | 3 | R | NED, 45 | |
| 19 | M | 64 | 5 | R | NED, 60 | |
| 20 | M | 41 | 3 | R | NED, 48 | |
| 21 | M | 51 | NR | L | NA | |
| 22 | F | 76 | NA | R | Rec, MT,6 | |
| 23 | M | 58 | 8 | Intrathoracic | NA | |
| Current case | M | 37 | 3 | L | NED, 12 |
L, left lobe; R, right lobe; LTF, lost to follow up; NED, no evidence of disease, NA, not available; Rec, recurrence; MT, metastasis.